Navigation Links
NeoStem Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy
Date:9/27/2010

NEW YORK, Sept. 27 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, appeared on Thursday at the NASDAQ  MarketSite in Times Square in connection with its announcement of the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.  

The definitive merger agreement provides for the issuance of an aggregate of 11,200,000 shares of NeoStem common stock in exchange for all of Progenitor Cell Therapy membership interests. The bulk of these shares will be held in an escrow account for at least one year from closing and will not be available for sale.  Additional consideration includes warrants to purchase an aggregate of no less than 1,000,000 and a maximum of 3,000,000 additional shares of NeoStem common stock at $3, $5 and $7 exercise prices. Holders of greater than 50% of NeoStem's common stock and greater than 50% of PCT's membership interests have agreed to vote in favor of the merger.Dr. Smith discussed how this acquisition is a significant step in NeoStem's efforts to develop a "one-stop-shop" for global cell therapy and highlighted key considerations in the merging of the two companies, including:

  • In 2009, PCT generated over $8,000,000 in revenue.  Its business will be accretive to NeoStem's growing adult stem cell operations and PCT has demonstrated that cellular therapy can be a revenue generating business.
  • PCT's management will remain in place.  They bring over 100 years of collective experience in the business and science of cell therapy and its development.
  • Since its inception in 1999, PCT has performed over 30,000  cell therapy procedures in its cell therapy manufacturing facilities and processed and stored over 18,000 cell therapy products (including
    '/>"/>

  • SOURCE NeoStem, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. FOX Business Network Airing In-Depth Look at NeoStem
    2. NeoStem to Present at Rodman & Renshaws 12th Annual Healthcare Conference
    3. NeoStem Provides Second Quarter Update
    4. NeoStem to Receive $700,000 from the U.S. Armys Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds
    5. NeoStem Named Best Stem Cell Company in The New Economys 2010 Biotech Awards
    6. NeoStem Achieves New Milestone as Company Joins Russell 3000 Index
    7. NeoStem Raises $5 Million in Registered Direct Offering
    8. NeoStem Selected to Present at American Society for Apheresis
    9. NeoStems Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference
    10. NeoStem to Ring Opening Bell at New York Stock Exchange on May 27, 2010
    11. NeoStem Announces Conversion of Convertible Preferred Stock by Principal Shareholder
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... GENEVA , July 11, 2014 ... pleased to announce the appointment of John P. ... Campus Biotech   in  Geneva . ... on Campus Biotech in Geneva , ... internationally recognised neuroscientists. John P. Donoghue , founder ...
    (Date:7/10/2014)... 10, 2014 Women in the ... to an additional family planning option. Sayana® Press ... at all levels of the health system and ... a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with ... is the first of four African countries expected ...
    (Date:7/10/2014)... Terascala, the industry leader in HPC ... former vice president of product management for Flexera Software, ... marketing. Terascala’s software when combined with leading compute and ... performance and most reliable solutions for processing big data. ... expansion and broaden its product portfolio. His leadership in ...
    (Date:7/10/2014)... July 10, 2014 EvoDerma ’s NOOME ... This rejuvenating device now comes with a second treatment cup ... time. , The new cup is thinner on the edges ... to target rough, thin and uneven surfaces on the face, ... for a stimulating treatment on areas such as the cheeks ...
    Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
    ... largest series of business-to-business IT events, is coming to Milwaukee again ... tradeshow and exposition will feature both global and Wisconsin-area technology companies. ... Gateway , Juniper Networks , Agilent , ... Solutions and Road Runner Business Class and other ...
    ... Middleton-based Bone Care International Inc. announced on Wednesday that ... , ,Genzyme and Bone Care have signed a definitive agreement ... all-cash transaction valued at $33.00 per fully diluted ... Bone Care's shareholders at a meeting on June 30, and ...
    ... bypass around Fond du Lac, Wis., opens later this ... a bridge like no other in the country. ... help to speed bridge-deck construction Externally, the bridge ... concrete deck reinforced with a novel fiber-reinforced polymer (FRP) ...
    Cached Biology Technology:Polymer grid technology a boon for bridges 2Polymer grid technology a boon for bridges 3
    (Date:7/11/2014)... eastern New South Wales, Australia when NASA,s Aqua satellite ... on July 11 (12:35 p.m. local time/11:35 p.m. EDT ... South Wales (NSW), the Moderate Resolution Imaging Spectroradiometer (MODIS) ... and spotted smoke (light brown) from various fires. Actively ... in red. , The New South Wales, Australia Government ...
    (Date:7/11/2014)... The University of Chicago is creating a new ... at the University,s Institute for Molecular Engineering and ... million donation from the Millicent and Eugene Bell ... will reside within the Institute for Molecular Engineering. ... research project at the MBL,s Eugene Bell Center ...
    (Date:7/11/2014)... researchers at the National Institute of Standards and ... their work more effectively, they often prove that ... was the case recently for M. Lorna De ... the growing specialization of glycomics. Glycomics is the ... glycans that are attached to proteins and lipids ...
    Breaking Biology News(10 mins):New professorship in tissue engineering links molecular engineering, marine biology 2
    ... fuel emissions, planting new forests, or managing existing forests ... ability to act as a carbon sink. Research published ... Management shows that although planting trees alone is unlikely ... a significant effect in the longer term. Rik ...
    ... Rochelle, NY, April 7, 2008 The American Medical ... of women in medicine and the improvement of women,s ... ) as its official journal. Journal of Womens Health ... Inc ( http://www.liebertpub.com ). We are proud to ...
    ... documentary An Inconvenient Truth is a powerful example of ... audience. What is up for debate is whether it ... caused by human activities. Climate change experts express their ... in articles just published online in Springers journal, GeoJournal. ...
    Cached Biology News:Forests' long-term potential for carbon offsetting 2Scientists debate the accuracy of Al Gore's documentary 'An Inconvenient Truth' 2
    ...
    ...
    ... is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long ... new radiolabeled ligands selected to keep pace ... range of products and services for receptor ... state-of-the-art radioligands. If you do not find ...
    ... DNase (patent pending) was developed using a protein ... the DNA binding pocket of wild-type DNase I. ... protein for DNA. The result is a versatile ... DNA, and an ability to maintain at least ...
    Biology Products: